162 related articles for article (PubMed ID: 14761161)
1. Virtual generation of agents against Mycobacterium tuberculosis. A QSAR study.
Besalú E; Ponec R; de Julián-Ortiz JV
Mol Divers; 2003; 6(2):107-20. PubMed ID: 14761161
[TBL] [Abstract][Full Text] [Related]
2. Similarity approach to QSAR. Application to antimycobacterial benzoxazines.
Gallegos A; Carbó-Dorca R; Ponec R; Waisser K
Int J Pharm; 2004 Jan; 269(1):51-60. PubMed ID: 14698576
[TBL] [Abstract][Full Text] [Related]
3. Syntheses and evaluation of benzodiazaborine compounds against M. tuberculosis H37Rv in vitro.
Davis MC; Franzblau SG; Martin AR
Bioorg Med Chem Lett; 1998 Apr; 8(7):843-6. PubMed ID: 9871552
[TBL] [Abstract][Full Text] [Related]
4. Influence of the replacement of the oxo function with the thioxo group on the antimycobacterial activity of 3-aryl-6,8-dichloro-2H-1,3-benzoxazine-2,4(3H)-diones and 3-arylquinazoline-2,4(1H,3H)-diones.
Waisser K; Gregor J; Dostál H; Kunes J; Kubicová L; Klimesová V; Kaustová J
Farmaco; 2001 Oct; 56(10):803-7. PubMed ID: 11718275
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
Ventura C; Latino DA; Martins F
Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure-activity relationships.
Kim P; Kang S; Boshoff HI; Jiricek J; Collins M; Singh R; Manjunatha UH; Niyomrattanakit P; Zhang L; Goodwin M; Dick T; Keller TH; Dowd CS; Barry CE
J Med Chem; 2009 Mar; 52(5):1329-44. PubMed ID: 19209893
[TBL] [Abstract][Full Text] [Related]
7. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation and 3D QSAR study of 2,4-disubstituted quinolines as anti-tuberculosis agents.
Patel SR; Gangwal R; Sangamwar AT; Jain R
Eur J Med Chem; 2015 Mar; 93():511-22. PubMed ID: 25747550
[TBL] [Abstract][Full Text] [Related]
9. Antimycobacterial pyrroles: synthesis, anti-Mycobacterium tuberculosis activity and QSAR studies.
Ragno R; Marshall GR; Di Santo R; Costi R; Massa S; Rompei R; Artico M
Bioorg Med Chem; 2000 Jun; 8(6):1423-32. PubMed ID: 10896119
[TBL] [Abstract][Full Text] [Related]
10. Substituted hydrazinecarbothioamide as potent antitubercular agents: synthesis and quantitative structure-activity relationship (QSAR).
Singh S; Mandal PK; Singh N; Misra AK; Singh S; Chaturvedi V; Sinha S; Saxena AK
Bioorg Med Chem Lett; 2010 Apr; 20(8):2597-600. PubMed ID: 20304645
[TBL] [Abstract][Full Text] [Related]
11. QSAR based therapeutic management of M. tuberculosis.
Ahamad S; Rahman S; Khan FI; Dwivedi N; Ali S; Kim J; Imtaiyaz Hassan M
Arch Pharm Res; 2017 Jun; 40(6):676-694. PubMed ID: 28456911
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antitubercular and anticancer activities of substituted furyl-quinazolin-3(4H)-ones.
Raghavendra NM; Thampi P; Gurubasavarajaswamy PM; Sriram D
Arch Pharm (Weinheim); 2007 Dec; 340(12):635-41. PubMed ID: 17994604
[TBL] [Abstract][Full Text] [Related]
13. Novel camphane-based anti-tuberculosis agents with nanomolar activity.
Stavrakov G; Valcheva V; Philipova I; Doytchinova I
Eur J Med Chem; 2013; 70():372-9. PubMed ID: 24177364
[TBL] [Abstract][Full Text] [Related]
14. Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines.
Asquith CRM; Fleck N; Torrice CD; Crona DJ; Grundner C; Zuercher WJ
Bioorg Med Chem Lett; 2019 Sep; 29(18):2695-2699. PubMed ID: 31378571
[TBL] [Abstract][Full Text] [Related]
15. Antitubercular constituents from the stem wood of Cinnamomum kotoense.
Chen FC; Peng CF; Tsai IL; Chen IS
J Nat Prod; 2005 Sep; 68(9):1318-23. PubMed ID: 16180806
[TBL] [Abstract][Full Text] [Related]
16. 3D-QSAR study of ring-substituted quinoline class of anti-tuberculosis agents.
Nayyar A; Malde A; Jain R; Coutinho E
Bioorg Med Chem; 2006 Feb; 14(3):847-56. PubMed ID: 16214351
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and 3D-QSAR analysis of 2-chloroquinoline derivatives as H37 RV MTB inhibitors.
Khunt RC; Khedkar VM; Coutinho EC
Chem Biol Drug Des; 2013 Dec; 82(6):669-84. PubMed ID: 23790070
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antimycobacterial activity of imidazo[1,2-b][1,2,4,5]tetrazines.
Maslov DA; Korotina AV; Shur KV; Vatlin AA; Bekker OB; Tolshchina SG; Ishmetova RI; Ignatenko NK; Rusinov GL; Charushin VN; Danilenko VN
Eur J Med Chem; 2019 Sep; 178():39-47. PubMed ID: 31176094
[TBL] [Abstract][Full Text] [Related]
19. Quantitative structure-activity relationship studies on nitrofuranyl anti-tubercular agents.
Hevener KE; Ball DM; Buolamwini JK; Lee RE
Bioorg Med Chem; 2008 Sep; 16(17):8042-53. PubMed ID: 18701298
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and QSAR studies of 4-substituted phenyl-2,6-dimethyl-3, 5-bis-N-(substituted phenyl)carbamoyl-1,4-dihydropyridines as potential antitubercular agents.
Desai B; Sureja D; Naliapara Y; Shah A; Saxena AK
Bioorg Med Chem; 2001 Aug; 9(8):1993-8. PubMed ID: 11504636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
